Cirrhosis is a progressive liver disease. In severe cases, cirrhosis can progress to decompensated cirrhosis. At this point, the liver loses function, and that may lead to serious symptoms and ...

Cirrhosis, a chronic liver disease, progressively replaces healthy cells with scar tissue, impairing detoxification and ...

In contrast, decompensated cirrhosis refers to when the liver can no longer function adequately. As such, a person living with compensated cirrhosis may not notice any symptoms.

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious complications like ascites and hepatic encephalopathy.

Decompensated cirrhosis, according to doctors, describes the complications of an advanced liver disease. Those with this condition are nearing end-stage liver failure and may need a liver ...

Decompensated cirrhosis is defined as an acute deterioration in liver function in a patient with cirrhosis and is characterized by jaundice, ascites, hepatic encephalopathy, hepatorenal syndrome ...

Lamivudine is an orally administered nucleoside analogue. The active compound, lamivudine triphosphate, competes with deoxycytidine triphosphate (dCTP) for incorporation into growing DNA chains ...

Source Reference: Pose E, et al "Simvastatin and rifaximin in decompensated cirrhosis: a randomized clinical trial" JAMA 2025; DOI: 10.1001/jama.2024.27441. Share on Facebook.

Adding combination treatment with simvastatin and rifaximin to standard therapy did not prevent severe complications in patients with decompensated cirrhosis, a European randomized trial found ...

Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030 Ramat Gan, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American ...